American College of Obstetricians and Gynecologists v. Hahn
American College of Obstetricians and Gynecologists v. Hahn (U.S. District Court of Maryland, July 13, 2020): The court required the Food & Drug Administration (FDA) to temporarily suspend enforcement of a restriction on medication used to terminate early pregnancies or manage miscarriages. Along with obtaining an in-person signature, the restriction requires a healthcare provider to dispense the medication in person. As a result of the COVID-19 pandemic, plaintiffs claimed that the in-person distribution requirement infringes on their constitutional right to an abortion and due process rights. The court determined this restriction may create an “undue burden” and a significant hardship for those seeking the medication, especially in light of the limited timeframe during which the medication must be taken. As a result, some patients would be forced to decide between delaying treatment or declining abortion care to avoid risking exposure to COVID-19. The court’s ruling will instead allow the medication to be mailed or delivered directly to patients. Read the full opinion here.